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Abstract
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma
(ATL) and inflammatory diseases. To enhance cell-to-cell transmission of HTLV-1, the virus
increases the number of infected cells in vivo. HTLV-1 bZIP factor (HBZ) is constitutively
expressed in HTLV-1 infected cells and ATL cells and promotes T-cell proliferation. How-
ever, the detailed mechanism by which it does so remains unknown. Here, we show that
HBZ enhances the proliferation of expressing T cells after stimulation via the T-cell receptor.
HBZ promotes this proliferation by influencing the expression and function of multiple co-
inhibitory receptors. HBZ suppresses the expression of BTLA and LAIR-1 in HBZ express-
ing T cells and ATL cells. Expression of T cell immunoglobulin and ITIM domain (TIGIT) and
Programmed cell death 1 (PD-1) was enhanced, but their suppressive effect on T-cell prolif-
eration was functionally impaired. HBZ inhibits the co-localization of SHP-2 and PD-1 in T
cells, thereby leading to impaired inhibition of T-cell proliferation and suppressed dephos-
phorylation of ZAP-70 and CD3ζ. HBZ does this by interacting with THEMIS, which associ-
ates with Grb2 and SHP-2. Thus, HBZ interacts with the SHP containing complex, impedes
the suppressive signal from PD-1 and TIGIT, and enhances the proliferation of T cells.
Although HBZ was present in both the nucleus and the cytoplasm of T cells, HBZ was local-
ized largely in the nucleus by suppressed expression of THEMIS by shRNA. This indicates
that THEMIS is responsible for cytoplasmic localization of HBZ in T cells. Since THEMIS is
expressed only in T-lineage cells, HBZ mediated inhibition of the suppressive effects of co-
inhibitory receptors accounts for how HTLV-1 induces proliferation only of T cells in vivo.
This study reveals that HBZ targets co-inhibitory receptors to cause the proliferation of
infected cells.
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Author Summary
Since HTLV-1 infects only through cell-to-cell transmission, increasing the number of
infected cells is critical for transmission of HTLV-1. Proliferation of HTLV-1 infected
cells is critical for development of leukemia and inflammatory diseases. In this study, we
showed that HBZ promotes the proliferation of infected cells by targeting co-inhibitory
receptors. Paradoxically, HBZ enhances the expression of the co-inhibitory receptors
TIGIT and PD-1. We found that HBZ concurrently hampers the growth-inhibitory signal
of TIGIT and PD-1, thereby leading to the enhanced proliferation of HTLV-1 infected
cells in vivo. HBZ does this by interacting with THEMIS, which is expressed only in T
cells. It is known that HTLV-1 infects different types of cells but increases only T cells.
Functional impairment of co-inhibitory receptors by interaction of HBZ with THEMIS is
a mechanism how HTLV-1 specifically induces proliferation of T cells.
Introduction
Human T-cell leukemia virus type 1 (HTLV-1) belongs to the delta type retrovirus group,
which also includes bovine leukemia virus and HTLV-2. HTLV-1 causes adult T-cell leuke-
mia-lymphoma (ATL) and inflammatory diseases [1–4]. This virus induces clonal prolifera-
tion of infected cells to enhance its transmission, since HTLV-1 is transmitted primarily by
cell-to-cell contact [5–7]. It has been reported that an increased number of infected cells is cor-
related with a higher rate of transmission by breast-feeding [8]. Thus, increased numbers of
HTLV-1 infected cells are beneficial for the transmission of this virus.
HTLV-1 encodes two regulatory genes, tax and rex, and three accessory genes (p12, p13,
and p30) in the plus strand of the provirus [2]. Another regulatory gene, the HTLV-1 bZIP factor
(HBZ) gene, is transcribed as an anti-sense transcript [9, 10]. It has been reported that HTLV-1
infected cells show higher susceptibility to antigenic stimulation. One mechanism of this hyper-
sensitivity is due to Tax. Tax expression under control of the long terminal repeat (LTR) results
in enhanced responsiveness to stimulation through the T-cell receptor (TCR)/CD3 complex
[11, 12]. However, Tax expression is often lost in ATL cells and HTLV-1 infected cells [13–18].
Therefore, it is likely that another mechanism also promotes proliferation of HTLV-1 infected
cells–perhaps a mechanism involving HBZ. Indeed, HBZ has been reported to promote prolif-
eration of T cells in vivo and in vitro [19, 20].
The TCR recognizes cognate antigenic peptides presented by major histocompatibility
complex molecules on antigen-presenting cells, and transduces a signal that is modulated
by co-stimulatory and co-inhibitory receptors on the T cell [21, 22]. It has been reported
that ATL cells and HTLV-1 infected cells express the co-inhibitory receptors PD-1 and T
cell immunoglobulin and ITIM domain (TIGIT) on their surfaces [23–25]. Binding of one
of these receptors to its ligand sends a suppressive signal through the ITIM or ITSM motif
in the cytoplasmic region of the receptor [21]. However, ATL cells and HTLV-1 infected
cells proliferate regardless of the higher expression of PD-1 and TIGIT on their surfaces.
Until now, it has not been known how the suppressive signal from these co-inhibitory
receptors is impaired.
In this study, we found that HBZ promotes T-cell proliferation mediated by TCR signaling.
As a mechanism, HBZ interferes with the suppressive function of some co-inhibitory receptors
and inhibits the expression of others. Thus, impairment of co-inhibitory receptors is a newly
discovered mechanism by which HTLV-1 promotes the proliferation of infected T cells.
HBZ Mediated Suppression of Co-inhibitory Receptors
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Results
Proliferation of CD4+ T cells of HBZ transgenic mice is promoted upon
TCR stimulation
We have reported that HBZ promotes proliferation of a human T-cell line and HBZ knock-
down inhibits proliferation of ATL cell lines [19]. Several mechanisms were identified for pro-
liferation induced by HBZ [20, 26–31]. However, it remains unknown how HTLV-1 induces
T-cell specific proliferation. We generated HBZ transgenic (HBZ-Tg) mice, in which HBZ is
expressed under the control of the CD4 promoter/enhancer/silencer, so that only CD4+ T cells
express HBZ [19, 32]. We also generated tax transgenic (tax-Tg) mice using the same promoter
[33]. We isolated CD4+ T cells from HBZ-Tg and tax-Tg mice and evaluated their proliferation
upon anti-CD3 stimulation. CD4+ T cells of HBZ-Tg mice proliferated much more than those
of non-transgenic (non-Tg) mice, and the proliferation of CD4+ T cells was slightly enhanced
in tax-Tg mice (Fig 1A and 1B). Co-culture of CD4+ T cells with dendritic cells (DC) further
enhanced this proliferation (Fig 1A and 1B). However, the difference in proliferation between
cells from HBZ-Tg and non-Tg mice was not observed in the presence of anti-CD28 antibody
(0.3 μg/mL) (Fig 1C), indicating that CD4+ T cells of HBZ-Tg mice are hypersensitive to sig-
naling via the TCR/CD3 complex.
To investigate whether the proliferation of CD4+ T cells of HBZ-Tg mice is increased in
vivo, we induced experimental allergic encephalomyelitis (EAE) in HBZ-Tg and non-Tg mice
by immunization with myelin oligodendrocyte glycoprotein (MOG)/complete Freund’s adju-
vant. Although disease severity was not different between HBZ-Tg mice and non-Tg mice (S1
Fig), the number of CD4+ T cells was increased only in the immunized HBZ-Tg mice com-
pared with non-immunized HBZ-Tg and non-Tg mice (Fig 1D), suggesting that HBZ-express-
ing T cells have higher susceptibility to immune stimulation in vivo. HBZ-Tg did not show
higher susceptibility to EAE regardless of impaired Treg function by HBZ [32]. It is speculated
that partial inhibition of Treg functions by HBZ is not enough to increase incidence of EAE.
Expression of co-stimulatory and co-inhibitory receptors on HBZ-
expressing T cells and ATL cells
It has been reported that HTLV-1 infected cells and ATL cells express both co-stimulatory
(OX40) and co-inhibitory receptors (PD-1 and TIGIT) on their surfaces [23, 25, 34, 35]. These
findings suggest that HTLV-1 influences expression of co-inhibitory and co-stimulatory recep-
tors. Therefore, we analyzed their expressions in HBZ-expressing T cells by real-time RT-
PCR. As shown in Fig 2A, the expression of the co-inhibitory receptors TIGIT and PD-1 was
enhanced, whereas transcription of other co-inhibitory receptors, BTLA and Lair-1, was sup-
pressed in HBZ transduced T cells. HBZ suppressed somewhat the transcription of the co-
stimulatory receptors CD28 and ICOS but did not influence that of OX40. In accordance with
this finding, flow cytometric analyses showed that in CD4+ T cells from HBZ-Tg mice, cell-
surface PD-1 and TIGIT were enhanced, while BTLA and LAIR-1 were decreased (Fig 2B and
2C). HBZ changed the cell-surface expression of co-stimulatory receptors only slightly or not
at all (S2 Fig). On the other hand, expression of co-inhibitory receptors did not differ on CD4+
T cells between tax-Tg and non-Tg mice (S3 Fig). Expression of HBZ and tax in these trans-
genic mice was confirmed by RT-PCR (S4 Fig).
To study whether similar changes in levels of these co-stimulatory and co-inhibitory recep-
tors are observed in ATL cells, we analyzed transcription and cell surface expression of these
co-receptors. As shown in Fig 3A and 3C, TIGIT transcription and expression were signifi-
cantly increased in ATL cases. PD-1 expression was upregulated in some ATL cases as reported
HBZ Mediated Suppression of Co-inhibitory Receptors
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Fig 1. HBZ promotes proliferation of CD4+ T cells upon TCR stimulation. (A, B) Proliferation of CD4+ T
cells isolated from non-Tg, tax-Tg and HBZ-Tg mice was analyzed by CFSE dilution. CD4+ T cells were
stimulated with soluble anti-CD3 antibody (30 ng/mL) and cultured with or without dendritic cells for three
days. (C) CD4+ T cells of non-Tg and HBZ-Tg mice were stimulated with immobilized anti-CD3 antibody (200
ng/mL) and soluble anti-CD28 antibody (0, 0.1, 0.3 and 1 μg/mL). CFSE dilution was analyzed by flow
cytometry. (D) Experimental allergic encephalomyelitis (EAE) was induced in non-Tg and HBZ-Tg mice by
immunization with MOG/CFA. The percentages of CD4+ T cells in spleen were measured in non-Tg and
HBZ-Tg mice.
doi:10.1371/journal.ppat.1006120.g001
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previously [24]. BTLA transcription and cell-surface expression were not different in ATL
cases compared with resting T cells, but suppressed compared with activated T cells (Fig 3A
and 3C). Cell-surface expression of LAIR-1 was also suppressed in ATL cells. Transcripts of
the HBZ and tax genes were measured by real-time RT-PCR in these cases (S5 Fig).
Fig 2. Expression of co-inhibitory receptors. (A) Transcripts of co-inhibitory and co-stimulatory receptor
genes were quantified in HBZ transduced mouse T cells by real-time RT-PCR. (B) Splenocytes of non-Tg or
HBZ-Tg mice (11 weeks old) were stained with anti-CD4, TIGIT, PD-1, BTLA and LAIR-1 antibodies. The
expression of co-inhibitory receptors in CD4+ T cells was analyzed by flow cytometry. (C) The mean
fluorescence intensity (MFI) of TIGIT, PD-1, BTLA and LAIR-1 in CD4+ T cells of non-Tg (n = 5) and HBZ-Tg
(n = 5) mice is shown.
doi:10.1371/journal.ppat.1006120.g002
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It makes sense that HBZ might decrease the expression of BTLA and LAIR-1, thus impair-
ing their suppressive function and enhancing the proliferation of infected cells. However,
enhanced expression of PD-1 and TIGIT would augment the suppressive function of these
co-inhibitory receptors, leading to decreased proliferation of cells. This idea is not consis-
tent with the observation that HBZ enhances proliferation of expressing T cells. Therefore,
we speculated that even though HBZ increases the expression of TIGIT and PD-1, it may
inhibit their suppressive function. On the other hand, expression of co-stimulatory recep-
tors, ICOS and OX40 was decreased in ATL cases compared with control activated CD4+ T
cells (S6 Fig).
Fig 3. Expression of TIGIT, PD-1, BTLA and Lair-1 in ATL cases. (A) Relative mRNA expression levels of
co-inhibitory receptors in resting healthy donor CD4+ T cells (n = 5), PHA-activated CD4+ T cells (n = 5) and
ATL cells (n = 14) were evaluated by real-time RT-PCR. (B) Cells from the same groups were stained with
anti-CD4, TIGIT, PD-1, BTLA and LAIR-1 antibodies. Expression of co-inhibitory receptors on CD4+ T cells
was analyzed by flow cytometry. (C) The MFI of TIGIT, PD-1, BTLA and LAIR-1 on the cells are shown.
doi:10.1371/journal.ppat.1006120.g003
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HBZ confers resistance to the suppressive effect of co-inhibitory
receptors
The co-inhibitory receptors PD-1 and TIGIT possess ITIM or ITSM domains, and inhibit cell
proliferation [21]. As described above, we hypothesized that HBZ may interfere with the T-cell
inhibitory function induced by PD-1/PD-L1 and/or TIGIT/CD155 interaction. To study this
possibility, we next analyzed the suppressive activity of TIGIT/CD155 interaction in the pres-
ence or absence of HBZ. CD4+ T cells were transduced with retroviruses expressing HBZ and
stimulated with anti-CD3/CD155.Fc-coated beads or anti-CD3/control.Fc-coated beads.
We then measured proliferation of the cells. As shown in Fig 4A, interaction with anti-CD3/
CD155.Fc-coated beads suppressed the proliferation of CD4+ T cells transduced with empty
vector, but not those transduced with HBZ, indicating that HBZ impairs TIGIT/CD155 medi-
ated growth inhibition. Likewise, HBZ interfered with the suppressive effect of PD-1/PD-L1
Fig 4. HBZ inhibits the suppressive effects of PD-1 and TIGIT. (A) HBZ-transduced murine primary CD4+
T cells were labeled with 5 μM CellTrace Violet and stimulated with anti-CD3/CD155.Fc-coated beads, anti-
CD3/PD-L1.Fc-coated beads, or anti-CD3/control.Fc-coated beads at a bead-to-cell ratio of 1:1 for three
days. CellTrace Violet dilution was analyzed by flow cytometry. (B) SHP-2 and PD-1 interaction in the
presence or absence of HBZ was analyzed by immunoprecipitation. Vectors expressing SHP-2-Flag and HBZ
(or mock)-IRES-mCD28/hPD1 were transfected into 293FT cells. After 48 hours, transfected cells were
stimulated with pervanadate for 5 min and cell lysates were immunoprecipitated with anti-mCD28 antibody.
doi:10.1371/journal.ppat.1006120.g004
HBZ Mediated Suppression of Co-inhibitory Receptors
PLOS Pathogens | DOI:10.1371/journal.ppat.1006120 January 3, 2017 7 / 24
interaction (Fig 4A). These data suggest that HBZ targets a common molecule(s) that is
involved in mediating suppressive signals from both PD-1 and TIGIT. Furthermore, suppres-
sive signal through BTLA was also inhibited by the presence of HBZ (S7 Fig). Thus, HBZ not
only suppresses BTLA expression but also functionally inhibits suppressive signaling from
BTLA.
Inhibitory signals through the ITIM and ITSM motifs of PD-1 and TIGIT are mediated by
SHP-1 and SHP-2 [21, 36, 37], negative regulators of TCR signaling that dephosphorylate
ZAP-70 and CD3z and suppress T-cell activation [38, 39]. We analyzed whether HBZ influ-
ences the interaction between the intracytoplasmic region of PD-1 and SHP-2. To study the
interaction of SHP-2 with the cytoplasmic region of PD-1, we generated a chimeric molecule
in which the intracytoplasmic region of human PD-1 was fused to the transmembrane and
extracytoplasmic regions of mouse CD28 (mCD28/hPD1) [40]. Pervanadate induces tyrosine
phosphorylation of intracellular proteins including PD-1, thus recruiting SHP-2 to the ITSM
motif [40]. After treatment with pervanadate, SHP-2 was recruited to the chimeric molecule
(Fig 4B, lane 2), while HBZ inhibited this interaction (lane 4). Thus, HBZ hinders recruitment
of SHP-2 to the ITSM motif of PD-1.
Binding of PD-L1 induces a transient PD-1-TCR co-localization within microclusters–a co-
localization that transiently associates with SHP-2 [41]. After stimulation by pervanadate, PD-
1 formed TCR microclusters in Jurkat cells as reported previously (S8 Fig). Next, we analyzed
the co-localization of PD-1 and SHP-2 after treatment with pervanadate to observe whether
HBZ inhibits the interaction between PD-1 and SHP-2. As shown in Fig 5A, SHP-2 co-local-
ized with PD-1 in Jurkat cells after pervanadate stimulation (stimulated Jurkat-mock). How-
ever, co-localization of these molecules was suppressed by the presence of HBZ (stimulated
Jurkat-HBZ).
To quantitatively analyze the co-localization of PD-1 and SHP-2, we visualized PD-1 and
SHP-2 using confocal microscopy. Captured raw images were analyzed using ImageJ software
with the JACoP plug-in, and Pearson’s correlation coefficient [an index for the relationship of
green (PD-1) and red (SHP-2) pixels] was calculated (Fig 5B). Co-localization of PD-1 and
SHP-2 in Jurkat mock-transfected cells was minimal without pervanadate stimulation (the
mean correlation coefficient value was 0.45), but these two molecules were highly co-localized
upon pervanadate stimulation (correlation coefficient of 0.72). This value decreased dramati-
cally, to 0.48, in the presence of HBZ (Jurkat-HBZ), indicating that HBZ strongly interferes
with the co-localization of PD-1 and SHP-2. These data show that HBZ inhibits recruitment of
SHP-2 to the cytoplasmic region of PD-1.
HBZ suppresses phosphorylation of SHP-2 and dephosphorylation of
ZAP-70
As shown above, HBZ inhibits the interaction between SHP-2 and PD-1. Indeed, phosphoryla-
tion of SHP-2 (Tyr580) was decreased in CD4+ T cells of HBZ-Tg mice (Fig 6A) and in HBZ-
transduced murine primary T cells (Fig 6B). SHP-2 functions to dephosphorylate ZAP-70 and
CD3z. After induction of phosphorylation by H2O2 [42], tyrosine phosphorylation of ZAP-70
lasted for a longer time in the presence of HBZ (Fig 6C). Similarly, tyrosine phosphorylation of
CD3z persisted longer after it was induced by pervanadate (Fig 6D). These data indicate that
HBZ interferes with the function of SHP-2, leading to suppressed dephosphorylation of ZAP-
70 and CD3z.
PD-1 suppresses T-cell proliferation not only by interacting with SHP-1 and SHP-2, but
also by interacting with PKCθ. Threonine phosphorylation (T538) of PKCθ is associated
with its activation and IL-2 production by T cells. Signaling via PD-1 inhibits PKCθ T538
HBZ Mediated Suppression of Co-inhibitory Receptors
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phosphorylation [43]. As shown in Fig 6E, HBZ did not enhance phosphorylation of PKCθ
T538, in contrast to ZAP-70 and CD3z. These results suggest that HBZ mediated activation of
TCR signaling is mainly through inhibition of the tyrosine phosphatase, SHP-2.
Fig 5. HBZ inhibits co-localization of PD-1 and SHP-2. (A) Staining of unstimulated or pervanadate-
stimulated Jurkat-mock and Jurkat-HBZ cells was performed using antibodies against PD-1 (green) and SHP-
2 (red). All scale bars are 5 μm. Three representative images derived from each sample are shown. Relative
fluorescence intensities of PD-1 (green line) and SHP-2 (red line) were obtained on the white dotted line. (B)
Co-localization of PD-1 and SHP-2 was judged by Pearson’s correlation coefficient between green and red
channels. Each circle represents an individual cell. Statistical analysis was performed using one-way ANOVA
with Tukey’s post hoc test.
doi:10.1371/journal.ppat.1006120.g005
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HBZ interacts with THEMIS
This study shows that HBZ inhibits the recruitment of SHP-2 to the cytoplasmic region of PD-
1. However, it remains unknown how HBZ interacts with the complex containing SHP-2.
Recently, THEMIS has been reported to interact with Grb2 and SHP-1 or 2, and inhibit T-cell
activation [44]. We analyzed the interaction of HBZ with these host factors and found that
Fig 6. Effect of HBZ on phosphorylation of SHP-2, ZAP-70, CD3ζ and PKCθ. (A) Phosphorylation levels of SHP-2 (Tyr580) in
CD4+ T cells of non-Tg and HBZ-Tg mice were analyzed by flow cytometry. Splenocytes of non-Tg or HBZ-Tg mice (8 weeks old)
were stained with anti-CD4 and pSHP-2 (Tyr580) antibodies. (B) The phosphorylation level of SHP-2 (Tyr580) of HBZ-transduced
murine primary CD4+ T cells was analyzed by flow cytometry. After HBZ transduction, cells were stimulated with anti-CD3/PD-L1.
Fc-coated beads at bead-to-cell ratio of 1:1 for 6 hours. (C-E) Dephosphorylation of ZAP-70, CD3ζ and PKCθwas analyzed by
immunoblotting (left). Jurkat-mock and Jurkat-HBZ cells were stimulated with 20 mM H2O2 or 0.5 mM pervanadate for 0, 5, 15, 30
or 45 min. Phosphorylation levels were also analyzed by densitometry (right). Relative protein levels were calculated as the ratio of
phosphorylated protein to total protein.
doi:10.1371/journal.ppat.1006120.g006
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HBZ binds to THEMIS, but not to Grb2 and SHP-2 (Fig 7A and S9 Fig), suggesting that
THEMIS is a target of HBZ. Next, we analyzed whether HBZ affects the interaction between
THEMIS and Grb2. We confirmed that THEMIS interacts with Grb2, and found that this
interaction is hindered by the presence of HBZ (Fig 7B and 7C). These data demonstrate that
HBZ interacts with THEMIS and partially impairs the association of THEMIS with Grb2. This
interaction of HBZ with the complex containing SHP may hinder recruitment of SHP to the
ITSM and ITIM motifs of co-inhibitory receptors such as PD-1.
Next, we analyzed whether HBZ interferes co-localization of PD-1 and THEMIS in the T
cells. Stimulation by pervanadate induced co-localization of PD-1 and THEMIS, which was
inhibited by HBZ (Fig 8A). Thus, HBZ interacts with THEMIS, which perturbs the complex
containing SHP and impairs suppressive signal from PD-1 or TIGIT. To check whether sup-
pressed THEMIS enhances T-cell proliferation through disrupted negative signal, we inhibited
THEMIS expression by shRNA and found that suppressed THEMIS expression decreased
T-cell proliferation (S10 Fig). It has been reported that proliferation of T cells from THEMIS
knockout mice was suppressed [45], suggesting that THEMIS is also critical for T-cell prolifer-
ation in addition to suppressive signaling from co-inhibitory receptors.
Fig 7. Interaction of HBZ with SHP associated factors. (A) Interaction between HBZ and THEMIS was
analyzed by immunoprecipitation. (B) Interaction between THEMIS and, Grb2 or SHP-2 or HBZ was analyzed by
immunoprecipitation. (A, B) Vectors expressing THEMIS, Grb2, SHP-2 and HBZ were transfected into 293FT cells
(3.5×106 cells, 10 cm dish). After 48 hours, transfected cells were stimulated with H2O2 for 5 min and cell lysates were
immunoprecipitated with anti-PA antibody or normal rat IgG as a control. (C) THEMIS and Grb2 interaction in the
presence or absence of HBZ was also analyzed with a densitometer. Relative protein levels were calculated as the
ratio of immunoprecipitated protein to total protein.
doi:10.1371/journal.ppat.1006120.g007
HBZ Mediated Suppression of Co-inhibitory Receptors
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Fig 8. Subcellular localization of HBZ and THEMIS. (A) Staining of unstimulated or pervanadate-stimulated Jurkat-mock and Jurkat-HBZ cells was
performed using antibodies against PD-1 (green) and THEMIS (red). All scale bars are 5 μm. Three representative images derived from each sample are
shown. Relative fluorescence intensities of PD-1 (green line) and THEMIS (red line) were obtained over white dotted line. (B) Localizations of HBZ (red)
and THEMIS (green) were analyzed in HBZ and/or THEMIS-transfected 293T cells. Nucleus was stained with DAPI (blue). Co-localization of HBZ and
THEMIS was found in co-transfected cells (indicated by arrowheads). Two representative images derived from each sample are shown. All scale bars are
30 μm. (C) Localization of HBZ in Jurkat-HBZ cells was detected using anti-HBZ antibody. Nucleus was stained with DAPI (blue). Scale bar is 10 μm. (D)
Expression of THEMIS was detected by immunoblotting in 293T cells and Jurkat cells. (E) Effect of THEMIS on the localization of HBZ was analyzed in
myc-tagged HBZ-introduced THEMIS-KD and luciferase-KD (served as a control) Jurkat cells. shRNA-expressing cells express GFP as a marker (shown
in gray). Cells were stained with antibodies against nuclear pore complex (NPC; green) and myc-tag (HBZ; red). Five representative images derived from
each sample are shown. All scale bars are 5 μm.
doi:10.1371/journal.ppat.1006120.g008
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THEMIS interacts with ITIM or ITSM domain of PD-1 and TIGIT in the cytoplasm
whereas it has been reported that HBZ is primarily localized in the nucleus [46]. Therefore,
localization of HBZ was analyzed in the presence of THEMIS. As reported previously, THE-
MIS existed in the cytoplasm (50 of 50 cells: 100%) whereas HBZ was mainly localized in the
nucleus of 293T cells (67 of 74 cells: 90.5%)(Fig 8B). When both proteins were expressed, HBZ
was co-localized with THEMIS in the cytoplasm (28 of 79 cells: 35.4%)(Fig 8B). Thus, THEMIS
shifted localization of HBZ from nucleus to cytoplasm in 293T cells. When we analyzed locali-
zation of HBZ in T cells, HBZ was detected in both the nucleus and the cytoplasm (Fig 8C).
Then, we analyzed THEMIS expression in 293T and Jurkat cells, and found that only Jurkat
cells expressed THEMIS (Fig 8D), suggesting that THEMIS is responsible for cytoplasmic
localization of HBZ.
To clarify the localization of HBZ in T cells in detail, we detected HBZ using antibody to
the nuclear pore complex, and confirmed that HBZ was present in both nucleus and cytoplasm
(Fig 8E). To study whether cytoplasmic localization of HBZ is attributed to THEMIS, we sup-
pressed THEMIS expression using shRNA, and found that HBZ was present largely in the
nucleus, suggesting that endogenous THEMIS contributes to changed localization of HBZ
from the nucleus to the cytoplasm (Fig 9).
Discussion
Co-stimulatory and co-inhibitory receptors control T-cell function and determine T-cell fate
after a T cell is stimulated by TCR signaling [21]. In this study, we showed that HBZ enhances
the susceptibility of expressing T cells to TCR-mediated signaling by perturbing signaling
from co-inhibitory receptors. This study is the first to demonstrate that HBZ targets various
co-inhibitory receptors by different mechanisms, and enhances proliferation. Expression of
BTLA and LAIR-1 is decreased by HBZ, while HBZ impairs the suppressive function of PD-1
and TIGIT through inhibited recruitment of the SHP-2 containing complex to the cytoplasmic
domain of PD-1. In contrast to BTLA and LAIR-1, expression of PD-1 and TIGIT are in fact
Fig 9. Schema of HBZ mediated inhibition of inhibitory signaling from co-inhibitory receptors. After T-cell activation
through TCR, PD-1 forms microcluster with TCR complex. Complex containing SHP-2, Grb2 and THEMIS recruits to ITSM or
ITIM motif of co-inhibitory receptors, PD-1 and TIGIT. SHP-1 dephosphorylates critical molecules for T-cell activation
including ZAP-70 and CD3ζ. HBZ interacts with THEMIS, which changes subcellular localization of HBZ. HBZ interferes
complex formation of THEMIS, Grb2 and SHP-2, which results in inhibition of suppressive signal from co-inhibitory receptors,
and enhanced activation of T cells.
doi:10.1371/journal.ppat.1006120.g009
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upregulated by HBZ. Why does HBZ enhance expression of TIGIT and PD-1 among co-inhib-
itory receptors? Increased TIGIT expression competes with CD226, a co-stimulatory receptor,
for binding with CD155, resulting in inhibition of T-cell activation [47]. In addition, HBZ
suppressed CD226 expression [25]. Furthermore, our previous study indicated that TIGIT
expressed on T cells is implicated in immune suppression through enhanced production of IL-
10 from T cells and DC by reverse signaling [25]. Since reverse signal from PD-L1 and L2 on
DC is also associated with suppressive phenotype of DC and moderate increase in IL-10
expression [48], PD-1 on T cells is also implicated in immune suppression. DC expresses the
TIGIT ligand, CD155, and PD-1 ligands, PD-L1 and PD-L2, on the surface. DC-T-cell inter-
action plays a key role in immune responses to viral infections [49]. We have reported that
increased expression of TIGIT on HBZ expressing T cells induces IL-10 production [25]. Fur-
thermore, IL-12p40 production of DC cells was severely impaired in HBZ-Tg mice, which is
likely caused by TIGIT on T cells [25, 47]. Thus HBZ suppresses host immune responses
through enhanced PD-1 and TIGIT expression while simultaneously impairing SHP-2 medi-
ated inhibitory signaling from these co-inhibitory receptors. In other words, HBZ modifies the
functions of the co-inhibitory receptors PD-1 and TIGIT to allow the virus to evade the host
immune system.
SHP-1 and 2 form complexes with Grb2 and THEMIS in T cells, and inhibit TCR mediated
signaling [44]. Knockdown of THEMIS increased TCR-induced CD3z phosphorylation, a phe-
nomenon that resembles the changes caused by HBZ. In this study, we show that HBZ inter-
acts with THEMIS and weakens the interaction between THEMIS and Grb2. These data
suggest that HBZ binding to THEMIS hinders recruitment of this complex to the ITSM motif
of PD-1 and thus impedes suppressive signals. THEMIS is expressed only in the T-cell lineage
[44, 50]. Therefore, it is thought that HBZ may not inhibit the co-inhibitory signal in non-T
cells. Since the receptor for HTLV-1 is glucose transporter 1, HTLV-1 infects a variety of cells
in vivo [51]. However, only infected T cells proliferate in vivo. Our observation that HBZ binds
to THEMIS and impairs the growth-suppressive signal might account for this T-cell specificity
of HTLV-1.
TCF-1 and LEF-1, transcription factors of classical Wnt signaling pathway, are critical for
T-cell development in the thymus [52], and their expressions are suppressed in peripheral
memory T cells. We have reported that TCF-1 and LEF-1 inhibit function of Tax, which may
critically influence the peripheral T-cell tropism of this virus [53]. It remains unknown how
this virus specifically promotes proliferation of infected mature T cells. This study reveals that
interaction between HBZ and THEMIS impedes suppressive signal by interfered recruitment
of SHP-2 to ITSM motif in T cells. This is thought to be a mechanism of T-cell specificity in
HTLV-1 induced proliferation. Thus, HBZ and Tax determine specificity of HTLV-1 infected
cells.
Analysis of the transcriptomes of 57 ATL cases using RNA-seq identified fusion gene prod-
ucts that contained five CD28-related in-frame fusions (CTLA4-CD28 or ICOS-CD28) that
likely induce continuous or prolonged CD28 co-stimulatory signaling [54]. In addition, ampli-
fication of CD28 was frequently detected in ATL cases. Thus the CD28 co-stimulatory mole-
cule is a frequent target of somatic changes in ATL cells. As shown in this study, HBZ perturbs
co-inhibitory signaling, which enhances proliferation of not only ATL cells but also other
HTLV-1 infected cells. Thus, in ATL cells, TCR signaling is a target of both somatic mutation
and HBZ. We assume that HBZ perturbs TCR signaling and promotes proliferation beginning
in individuals at the carrier state, and then somatic mutations potentiate and exacerbate the
proliferative responses.
Recently it has been reported that structural variations in the 3’ untranslated region of
PD-L1 enhanced PD-L1 expression in various cancer cells [55]. In particular, these structural
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variations were frequently observed in ATL (27% of 49 ATL cases). Overexpression of PD-L1
on ATL cells inhibits immune attack from CD8+ T cells through interaction with PD-1. Since
ATL cells also express PD-1, PD-L1 might suppress the proliferation of ATL cells. However,
since HBZ interrupts the suppressive signal from PD-1 through inhibited recruitment of the
SHP containing complex to the ITSM motif, ATL cells avoid growth suppression while main-
taining the immune suppressive effects of PD-1/PD-L1 interaction on CD8+ T cells.
HBZ is primarily localized in the nucleus [46], and interacts with transcription factors,
which include p65, Smad3, and c-Jun, and other host factors such as p300 in the nucleus [56–
59]. However, it has been reported that HBZ interacts with GADD34 in the cytoplasm, which
activates the mammalian target of rapamycin (mTOR) signaling [60]. This finding suggests
that HBZ also functions in the cytoplasm by interacting with host factors. This study showed
that interaction of HBZ with THEMIS changes its localization and HBZ functions in the cyto-
plasm, and HBZ interferes suppressive function of co-inhibitory receptors. Thus, HBZ exerts
the functions in both nucleus and cytoplasm.
In this study, we demonstrate that HBZ inhibits suppressive signaling from co-inhibitory
receptors by decreased transcription or by inhibition of recruitment of SHP-2. Furthermore,
HBZ enhances the expression of TIGIT and PD-1, which are associated with immune suppres-
sion. Thus, HBZ enables expressing T cells to survive and proliferate in vivo by utilizing and
modifying the functions of co-inhibitory receptors.
Materials and Methods
Mice
C57BL/6J mice were purchased from CLEA Japan. Transgenic mice expressing HBZ (HBZ-Tg
mice) under the control of the murine CD4-specific promoter/enhancer/silencer have been
described previously [19]. All HBZ-Tg mice were heterozygotes for the transgene. Transgenic
mice expressing tax (tax-Tg mice) under the control of the same promoter were generated as
reported [33].
Cells
Jurkat cell line was provided by Dr. S. Sakaguchi (Osaka University, Japan). Jurkat cell lines
stably expressing the spliced form of HBZ (Jurkat-HBZ) and control (Jurkat-mock) cells were
cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and 1 mg/
mL G418 (Nacalai Tesque, Kyoto, Japan) [61]. The 293T cell line was purchased from ATCC
(Manassas, VA, USA) and cultured in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 10% FBS. The 293FT cell line was purchased from Life Technologies and cultured
in DMEM supplemented with 10% FBS and 0.5 mg/mL G418. The packaging cell line, Plat-E,
was provided by Dr. T. Kitamura (Institute of Medical Science, The University of Tokyo,
Japan) and cultured in DMEM containing 10% FBS, 10 μg/mL blasticidin and 1 μg/mL puro-
mycin. These cell lines were grown at 37˚C under a 5% CO2 atmosphere.
Clinical samples
Peripheral blood mononuclear cells (PBMCs) of ATL patients and healthy donors were col-
lected by Ficoll-Paque PLUS (GE Healthcare, Little Chalfont, UK). CD4+ T cells of healthy
donors were isolated by Human CD4+ T Cell Enrichment Cocktail (STEMCELL Technologies,
Vancouver, Canada) according to the manufacturer’s instructions. To obtain activated CD4+
T cells, CD4+ T cells were stimulated by 10 μg/mL phytohemagglutinin (PHA) (Sigma-
Aldrich, St. Louis, MO, USA) for three days.
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Ethics statement
Animal experiments were performed in strict accordance with the Japanese animal welfare
bodies (Law No. 105 dated 19 October 1973, modified on 2 June 2006), and the Regulation on
Animal Experimentation at Kyoto University. The protocol was approved by the Institutional
Animal Research Committee of Kyoto University (permit numbers D13-02, D14-02, D15-02,
and A10-3). Experiments using clinical samples were conducted according to the principles
expressed in the Declaration of Helsinki, and approved by the Institutional Review Board of
Kyoto University (permit number G310). ATL patients and healthy blood donors provided
written informed consent for the collection of samples and subsequent analysis.
Plasmids
pMX-IG, pMX-HBZ-IG and pMX-BTLA-IG were used for retrovirus production. The coding
sequence of BTLA was amplified from cDNA of a wild type C57BL/6J mouse, and subcloned
into pMX-IG. The HBZ expression vector, pcDNA3.1 HBZ-mycHis, was described previously
[58]. The SHP-2 expression vector, pSP65SRa-SHP2-Flag, was kindly given by Dr. M. Hata-
keyama (The University of Tokyo, Japan). The entire coding regions of Grb2 and THEMIS
were amplified from cDNA prepared from resting human PBMCs or Jurkat cells. These PCR
fragments were subcloned into pCMV-HA (Clontech Laboratories, Palo Alto, CA, USA) or
pCAGGS-PA. The resulting plasmids were designated pCMV-HA-Grb2 and pCAGGS-PA-
THEMIS, and they express HA (YPYDVPDYA)-tagged Grb2 and PA (GVAMPGAEDDVV)-
tagged THEMIS, respectively. For generation of the chimeric mCD28/human PD-1 (hPD-1)
expression vector, the mCD28 extracellular and transmembrane domains (bases 9–617 of
NM_007642) were amplified from cDNA prepared from stimulated murine T cells, and the
hPD-1 intracellular domain (bases 645–935 of NM_005018) was amplified from cDNA pre-
pared from PHA-stimulated human PBMCs. These fragments were ligated and the resultant
fragment was substituted for the GFP cording region of pMX-HBZ-IRES-GFP.
Preparation of antibody-coupled beads
Anti-CD3 antibody (145-2X11, R&D systems, Minneapolis, MN, USA) together with recombi-
nant mouse CD155.Fc or the control.Fc (Sino Biological, Beijing, China) or PD-L1. Fc or the
control.Fc (R&D systems) or HVEM.Fc (R&D systems) were covalently attached to Dynabeads
M450 Tosylactivated (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA). Anti-CD3
antibody together with control.Fc was used for the control. For each 107 beads, 1 μg of anti-
CD3 antibody (20% of total protein) and 4 μg of CD155.Fc, PD-L1.Fc, HVEM.Fc or control.Fc
(80%) were used.
Generation of THEMIS knock-down Jurkat cells
The PiggyBac-based shRNA expression vector, pB-CMV-GreenPuro-H1 (System Biosciences,
Palo Alto, CA, USA), containing shRNA against THEMIS or luciferase (control), was intro-
duced into Jurkat cells together with PiggyBac transposase expression vector by using Neon
Transfection System (Invitrogen). Target sequences of each shRNA are shown in S1 Table.
Cell proliferation assay
To measure the proliferation of CD4+ T cells of HBZ-Tg mice, we isolated murine splenic
CD4+ T cells using the CD4 T Lymphocyte Enrichment Set (BD Biosciences, San Jose, CA,
USA). Murine splenic dendritic cells were isolated from collagenase-digested low-density cells
using the Dendritic Cell Enrichment Set (BD Biosciences). Purified CD4+ T cells were labeled
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with 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular Probes,
Thermo Fisher Scientific, Waltham, MA, USA). Labeled CD4+ T cells of HBZ-Tg, non-Tg and
tax-Tg mice (2×105 cells/well) were cultured with or without dendritic cells (1×104 cells/well)
from non-Tg mice for three days with soluble anti-CD3 antibody (30 ng/mL) stimulation in
round-bottomed 96-well plates. CFSE dilution was analyzed by flow cytometry. For TIGIT/
CD155 and PD-1/PD-L1 proliferation assays, HBZ or empty vector transduced cells (see
below) were labeled with CellTrace Violet (Invitrogen) and stimulated with anti-CD3/CD155.
Fc or anti-CD3/PD-L1.Fc or anti-CD3/control.Fc-coated beads at a bead-to-cell ratio of 1:1
for three days. Dye dilution was analyzed by flow cytometry.
Retroviral transduction
Transfection of the packaging cell line, Plat-E, was performed as reported [62]. Murine CD4+
T cells were activated by immobilized anti-CD3 (1 μg/mL) and soluble anti-CD28 (0.1 μg/mL)
in 12-well plates. After 24 hours, activated T cells were transduced with virus supernatant and
4 μg/mL polybrene, and centrifuged at 3,000 rpm for 60 min. Cells were subsequently cultured
for 48 hours.
Real-time RT-PCR
Total RNA was isolated using Trizol Reagent (Invitrogen) and treated with DNase I to remove
the genomic DNA. cDNAs were synthesized from 1 μg of total RNA using random primer and
SuperScript III or IV reverse transcriptase according to the manufacturer’s instructions (Invi-
trogen). mRNA expression was analyzed by real-time PCR using FastStart Universal SYBR
Green Master (Roche Diagnostics, Basel, Switzerland) and the StepOnePlus Real-Time PCR
System (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA) according to the
manufacturer’s instructions. Primers used in this study are shown in S1 Table.
Flow cytometric analysis
The following antibodies were used for flow cytometric analyses. Anti-mCD4 (GK1.5), mTI-
GIT (IG9), mCD28 (E18), mICOS (C398.4A), mOX40 (OX-86), hCD4 (RPA-T4), hPD-1
(29F.1A12), hBTLA (MIH26), hLAIR-1 (NKTA255), hCD28 (CD28.2), hICOS (C398.4A) and
hOX40 (Ber-ACT35) antibodies were all purchased from BioLegend (San Diego, CA, USA).
Anti-mBTLA (6F7), mLAIR-1 (113) and hTIGIT (MBSA43) antibodies were purchased from
eBioscience (San Diego, CA, USA). Anti-mPD-1 (J43) was from BD Pharmingen (BD Biosci-
ences). Anti-phospho-SHP-2 (Tyr580) antibody was from Cell Signaling Technology (Dan-
vers, MA, USA). Anti-mouse IgG1, mouse IgG2b and rat IgG1 (BioLegend), Armenian
hamster IgG (eBiosciences) and mouse IgG2a (BD Pharmingen) were purchased for isotype
controls. For detection of SHP-2 phosphorylation, cells were permeabilized using BD Phosflow
perm buffer II (BD Biosciences) according to the manufacturer’s instructions. Flow cytometric
analysis was carried out using a FACSVerse with FACSuite software (BD Biosciences) and
FlowJo (TreeStar, Ashland, OR, USA).
Experimental autoimmune encephalomyelitis (EAE)
For the induction of EAE, five to seven-week old HBZ-Tg or control non-transgenic (non-Tg)
C57BL/6J mice were immunized with an emulsion containing MOG peptide 35–55 (MEVG-
WYRSPFSRVVHLYRNGK). The emulsion was prepared by sonication, mixing 1 mL of MOG
solution (1 mg/mL in PBS) with 1 mL of complete Freund’s adjuvant (Difco Laboratories,
Detroit, MI, USA) containing desiccated Mycobacterium butyricum. The emulsion was
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injected subcutaneously in the area near the axillary lymph nodes and on both sides at the base
of the tale of each mouse (50 μL/site, a total of 4 sites/mouse). On days 0 and 2 post-immuniza-
tion, mice were injected intraperitoneally with 50 μL of a Pertussis toxin (Kaketsuken, Kuma-
moto, Japan) solution (4 μg/mL). Thereafter, mice were monitored daily for clinical signs of
encephalomyelitis. A clinical score was assigned according to the following criteria: 0, no
symptoms; 1, mild limp tail; 1.5, limp tail; 2, unilateral hind limb weakness or abnormal gait;
2.5, unilateral hind limb paralysis or bilateral hind limb weakness; 3, paraplegia; 3.5, unilateral
fore limb weakness, with paraplegia; 4, unilateral fore limb paralysis or bilateral fore limb
weakness; 4.5, bilateral fore limb paralysis; 5, moribund or dead.
Immunoprecipitation
For the immunoprecipitation studies of SHP-2 and PD-1, 293FT cells were transfected with
the indicated expression vectors using Lipofectamine LTX (Invitrogen) according to manufac-
turer’s instructions. After 48 hours, cells were stimulated with 0.1 mM pervanadate solution
for 5 min. The cell lysates were immunoprecipitated for 60 min at 4˚C with 5 μg of anti-
mCD28 (37.51), and immune complexes were incubated with Protein G-Sepharose (GE
Healthcare) for 60 min at 4˚C. For the immunoprecipitation studies of THEMIS, Grb2, SHP-2
and HBZ, 293FT cells were transfected as described above. After 48 hours, cells were stimu-
lated with H2O2 for 5 min. The cell lysates were immunoprecipitated with 20 μg of anti-PA
(NZ-1), anti-HA (HA-7) or anti-Flag (M2) antibodies, and immune complexes were incubated
as described above. Normal mouse and rat IgG (Santa Cruz Biotechnology, Dallas, TX, USA)
were used as controls.
Immunoblotting
The following antibodies were used for immunoblotting: anti-phospho-SHP-2 (Tyr580), phos-
pho-ZAP-70 (Tyr319 and Tyr493), ZAP-70 (99F2), phospho-PKCθ (Thr538) and PKCθ
(E1I7Y) antibodies were purchased from Cell Signaling Technology. Anti-phosphor-CD3z
(Tyr83), CD3z and anti-THEMIS were purchased from Abcam (Cambridge, UK). Anti-PA
(NZ-1) was purchased from Wako, Osaka, Japan. Anti-Flag-HRP (M2), HA-HRP (HA7), Myc
(9E10), and tubulin (DM1A) antibodies were purchased from Sigma-Aldrich. Anti-mouse
IgG-HRP, rabbit IgG-HRP and rat IgG-HRP antibodies were purchased from GE Healthcare.
Mouse anti-HBZ monoclonal antibody (clone 1A10) was generated by immunizing C57BL/6
with using keyhole limpet hemocyanin (KLH)-conjugated HBZ peptide 97–133 (CKQIAEYL
KRKEEEKARRRRRAEKKAADVARRKQEEQE).
Immunofluorescence analysis
To detect co-localizations of PD-1 with SHP-2, THEMIS or TCR, Jurkat-mock or Jurkat-HBZ
cells were stimulated with 0.2 mM pervanadate solution for 2 min at 37˚C. To evaluate the
effect of THEMIS on the localization of HBZ, THEMIS-knocked down (KD) and control
(luciferase KD) Jurkat cells were transfected with pcDNA 3.1 HBZ-mycHis or empty vector.
The cells were washed with PBS and placed on MAS-coated glass slides (Matsunami Glass,
Osaka, Japan). To detect HBZ, 293T cells cultured on type I collagen (Cellmatrix, Nitta Gela-
tin, Osaka, Japan)-coated coverslips, were transfected with pcDNA 3.1 HBZ-mycHis and/or
pCAGGS-PA-THEMIS. The cells were fixed with 4% paraformaldehyde for 15 min, permeabi-
lized with 0.2% Triton X-100 for 15 min, and blocked by incubation in 5% donkey serum
(Jackson ImmunoResearch, West Grove, PA, USA) for 60 min. For immunostaining, the cells
were incubated with anti-SHP-2 (sc-280), anti-PD-1 (sc-10297), anti-TCR β (sc-5277) (all
Santa Cruz Biotechnology), anti-THEMIS (ab126771), anti-Nuclear Pore Complex Proteins
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(ab24609) (all Abcam), anti-myc (9E10, Sigma-Aldrich or Abcam) or anti-PA (NZ-1) antibod-
ies for 60 min, followed by incubation with Alexa Fluor 488-conjugated donkey anti-goat IgG,
Alexa Fluor 488-conjugated donkey anti-rat IgG, Alexa Fluor 594-conjugated donkey anti-
mouse IgG, Alexa Fluor 594-conjugated donkey anti-rat IgG, Alexa Fluor 647-conjugated don-
key anti-mouse IgG or Alexa Fluor 647-conjugated donkey anti-rabbit IgG antibodies (all Invi-
trogen), or DyLight 405-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch) for
30 min. The stained cells were mounted with ProLong Gold Antifade Reagent or ProLong
Gold Antifade Reagent with DAPI (all Molecular Probes, Thermo Fisher Scientific), imaged
using an FV1000 confocal microscope (Olympus, Tokyo, Japan) or a Leica TCS SP8 (Leica
Microsystems, Wetzlar, Germany), and analyzed with ImageJ.
Statistical analyses
For Figs 1, 2, 7, S2 and S10, statistical significance was determined by the two-tailed unpaired
Student’s t-test. For Figs 3, 5 and S6, statistical analysis was performed using the one-way
ANOVA with Tukey’s post hoc test (GraphPad Prism, GraphPad Software, La Jolla, CA,
USA). Asterisks indicate the statistical significance as follows: P< 0.05; P< 0.01;
P< 0.001; n.s., not significant.
Supporting Information
S1 Fig. Severity of EAE did not differ between HBZ-Tg and non-Tg mice. EAE was induced
in HBZ-Tg and control mice. These mice were monitored daily for symptoms, and clinical
scores were determined. The graph shows the average values at the indicated time-points for
the HBZ-Tg (n = 7) and the control non-Tg (n = 5) mice. The induction of EAE and determi-
nation of clinical scores are described in the Materials and Methods section.
(PPTX)
S2 Fig. Expression of co-stimulatory receptors in CD4+ T cells of HBZ-Tg and non-Tg
mice. (A) Splenocytes of non-Tg or HBZ-Tg mice (11 weeks old) were stained with anti-CD4,
CD28, ICOS and OX40 antibodies. Expression of co-stimulatory receptors in CD4+ T cells was
analyzed by flow cytometry. (B) MFI of CD28, ICOS and OX40 in CD4+ T cells of non-Tg
(n = 5) and HBZ-Tg mice (n = 5).
(PPTX)
S3 Fig. Expression of co-inhibitory receptors in CD4+ T cells of tax-Tg and non-Tg mice.
Expression of co-inhibitory receptors (TIGIT, PD-1, BTLA and LAIR-1) was analyzed on
CD4+ T cells from tax-Tg and non-Tg mice.
(PPTX)
S4 Fig. Expression of tax or HBZ in CD4+ T cells of non-Tg, tax-Tg and HBZ-Tg mice.
Transcripts of the HBZ and tax genes were detected by RT-PCR in CD4+ T cells from non-Tg,
tax-Tg, and HBZ-Tg mice.
(PPTX)
S5 Fig. Expression of HBZ and tax in ATL cells. Transcripts of the HBZ and tax genes were
measured by real-time RT-PCR in ATL cases (n = 14) that were used in Fig 3.
(PPTX)
S6 Fig. Expression of co-stimulatory receptors in CD4+ T cells of healthy donors and ATL
patients. (A) Relative expression levels of co-stimulatory receptors on resting CD4+ T cells,
activated CD4+ T cells and CD4+ T cells of ATL patients were evaluated by real-time RT-PCR.
(B) Expression of the co-stimulatory receptors CD28, ICOS and OX40 on CD4+ T cells was
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analyzed by flow cytometry. (C) Expression of CD28, ICOS and OX40 in CD4+ T cells is
shown.
(PPTX)
S7 Fig. HBZ inhibits the suppressive effect of BTLA. BTLA-transduced murine primary
CD4+ T cells of non-Tg or HBZ-Tg mice were labeled with 5 μM CellTrace Violet and stimu-
lated with anti-CD3/HVEM.Fc-coated beads or anti-CD3/control.Fc-coated beads at a bead-
to-cell ratio of 1:1 for three days. CellTrace Violet dilution was analyzed by flow cytometry.
(PPTX)
S8 Fig. Co-localization of PD-1 and TCRβ after stimulation by pervanadate. Co-localiza-
tion between PD-1 (green) and TCRβ (red) was analyzed in unstimulated and pervanadate-
stimulated Jurkat-mock cells. All scale bars are 2 μm. Relative fluorescence intensities of PD-1
(green line) and TCRβ (red line) were obtained over white dotted line.
(PPTX)
S9 Fig. HBZ does not interact with SHP-2 and Grb2. Interaction between HBZ with SHP-2
(A) or Grb2 (B) was analyzed by immunoprecipitation. Vectors expressing Grb2, SHP-2 and
HBZ were transfected into 293FT cells (3.5×106 cells, 10-cm dish). After 48 hours, transfected
cells were stimulated with H2O2 for 5 min and cell lysates were immunoprecipitated with anti-
Flag or anti-HA antibodies or normal rat IgG as a control.
(PPTX)
S10 Fig. Effect of THEMIS knockdown in T cells. (A) THEMIS expression was measured in
control Jurkat cells and THEMIS knockdown Jurkat cells by Western blot method. (B) The
shRNA-expressing Jurkat cells were seeded into 96-well plates (1×104 cells/well). Cell numbers
of each shRNA-expressing Jurkat cells were counted in triplicate by Trypan blue dye exclusion
method.
(PPTX)
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